As a father of a son who’s T1D , this is a wonderful news and brings big hope. Don’t listen to the negative voices just keep moving ahead. We need this today.
I have T1D and am an engineer. It's great that you have proof of concept. I don't want to sound negative, but that process for encapsulation sounds difficult to scale, and the burden and cost of a lifetime of anti-rejection medication is not insignificant. So two questions: 1) Are there any early estimates for cost of production per patient and lifetime therapy costs that would make insurers interested in supporting the development and later covering this therapy when it becomes available at scale in 5-10 years? 2) Is your company publicly traded? (This is a development effort that I'd be interested in supporting as a small investor. )
I would like to ask your guest one thing: What about type one diabetes patients without antibodies and no Modi? My son is that case, and all I could find is that they are understudy group of people. In my mind, he would be perfect patient for that pouch. Right?
Stacy,when a positive decision is made after the conference between sernova and fda can sernova enters into phase 3 trials on the stem cell/ cell pouch for type one conference at March in Chicago .
This is great but keep in mind that sernova is using a mesh made of plastic called polypropylene for their cell pouch. This will have all kinds of problems for the patient which sernova will undoubtedly downplay or hide in their clinical trials. They will also somehow justify the use of this woven mesh by saying the same mesh is used when hiatal hernia patients get surgery. This is true but see the number of lawsuits that the same mesh manufacturers are facing because of the pain and other long term side effects caused in the body when this mesh is used. Just not worth it and really unfortunate that sernova haven't thought this through despite the product showing so much promise for a potential cure. Hopefully vertex don't have a similar mesh like pouch.
